La vendita allo scoperto per Aspen Aerogels dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Aspen Aerogels. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Aspen Aerogels (NYSE:ASPN) Azioni, Report sulle vendite allo scoperto

Aspen Aerogels

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Aspen Aerogels Inc

Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Aspen Aerogels will report an earnings per share (EPS) of $-0.08.
Anticipation surrounds Aspen Aerogels's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.17, leading to a 16.0% increase in the share price the following trading session.
Here's a look at Aspen Aerogels's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.04</td>
<td>-0.11</td>
<td>-0.12</td>
<td>-0.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.21</td>
<td>-0.02</td>
<td>-0.01</td>
<td>-0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>16.0%</td>
<td>56.99999999999999%</td>
<td>16.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730833388_0.png" alt="eps graph" />
<h3>Performance of Aspen Aerogels Shares</h3>
Shares of Aspen Aerogels were trading at $18.25 as of November 04. Over the last 52-week period, shares are up 89.9%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Insights Shared by Analysts on Aspen Aerogels</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Aspen Aerogels.
The consensus rating for Aspen Aerogels is Buy, based on 6 analyst ratings. With an average one-year price target of $30.67, there's a potential 68.05% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Ingevity, Valhi and Perimeter Solutions, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, Ingevity is favoring an Neutral trajectory, with an average 1-year price target of $43.5, suggesting a potential 138.36% upside.</li>
<li>As per analysts' assessments, Valhi is favoring an Underperform trajectory, with an average 1-year price target of $20.0, suggesting a potential 9.59% upside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Perimeter Solutions, with an average 1-year price target of $14.5, indicating a potential 20.55% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary outlines pivotal metrics for Ingevity, Valhi and Perimeter Solutions, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>144.55%</td>
<td>$51.58M</td>
<td>3.33%</td>
</tr>
<tr>
<td>Ingevity</td>
<td>Neutral</td>
<td>-15.49%</td>
<td>$129.90M</td>
<td>-42.94%</td>
</tr>
<tr>
<td>Valhi</td>
<td>Underperform</td>
<td>10.37%</td>
<td>$121.30M</td>
<td>2.10%</td>
</tr>
<tr>
<td>Perimeter Solutions</td>
<td>Neutral</td>
<td>67.17%</td>
<td>$73.27M</td>
<td>2.04%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Aspen Aerogels ranks highest in Revenue Growth among its peers, showing a significant increase. In terms of Gross Profit, Aspen Aerogels is at the top with a strong performance. However, its Return on Equity is moderate compared to others. Overall, Aspen Aerogels is positioned well compared to its peers in key financial metrics.
<h3>Unveiling the Story Behind Aspen Aerogels</h3>
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
<h3>Key Indicators: Aspen Aerogels's Financial Health</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Aspen Aerogels's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 144.55% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Aspen Aerogels's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.28% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Aspen Aerogels's ROE stands out, surpassing industry averages. With an impressive ROE of 3.33%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Aspen Aerogels's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.33%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.29.
<a href="https://www.benzinga.com/quote/ASPN/earnings">To track all earnings releases for Aspen Aerogels visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ASPN

What's Next: Aspen Aerogels's Earnings Preview

Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) has outperformed the market over the past 5 years by 13.55% on an annualized basis producing an average annual return of 27.47%. Currently, Aspen Aerogels has a market capitalization of $1.57 billion. 
Buying $1000 In ASPN: If an investor had bought $1000 of ASPN stock 5 years ago, it would be worth $3,343.19 today based on a price of $20.36 for ASPN at the time of writing.
<h3>Aspen Aerogels's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729607605_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,300 Today

Piper Sandler analyst Alexander Potter maintains Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Overweight and lowers the price target from $36 to $33.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Aspen Aerogels, Lowers Price Target to $33

Aspen intends to use the net proceeds from the offering for working capital, capital expenditures and general corporate purposes.

Reported Earlier, Aspen Aerogels Prices $85M Public Offering Of 4.25M Common Shares At $20/Share

Aspen&nbsp;intends to use the net proceeds from the offering for working capital, capital expenditures and general corporate purposes.

Offerings

Aspen Aerogels  Commences Public Offering Of 4.25M Shares Of Its Common Stock

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Buy and maintains $30 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on Aspen Aerogels, Maintains $30 Price Target

Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares are trading higher after the company won a conditional commitment for a proposed DOE <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41355398/aspen-aerogels-inc-receives-conditional-commitment-for-proposed-doe-loan-and-provides-q3-2024-prel" rel="noreferrer noopener">loan worth up to $670.6 million</a>.
This loan, part of the Advanced Technology Vehicles Manufacturing program, will finance the construction of Aspen&#8217;s second aerogel manufacturing facility in Register, Georgia.
Although the conditional commitment signifies the DOE&#8217;s intent to finance the project, both the DOE and Aspen Aerogels must meet specific technical, legal, environmental, and financial conditions before finalizing the loan agreement and disbursing funds.
The Register Plant will manufacture PyroThin aerogel blankets, ultrathin thermal barriers designed to prevent thermal runaway in batteries.&nbsp;&nbsp;
The plant is projected to generate $1.2 billion to $1.6 billion in initial revenue and create up to 550 construction jobs and 255 permanent positions.
Donald R. Young, Aspen&#8217;s President and CEO, said, &#8220;We believe that PyroThin, which can enable increased battery safety and performance, is a unique and differentiated product that solves an important and challenging problem.&#8221;
&#8221;We are also excited to further DOE&#8217;s mission to onshore and re-shore domestic manufacturing technologies that are critical to meeting the current federal goal of having half of all new vehicles sold in 2030 be zero-emissions vehicles.&#8221;
Outlook: Additionally, the company announced preliminary results for the third quarter of 2024.
The company expects quarterly revenue of approximately $117 million (vs. consensus of $95.5 million) and a net loss of around $13 million, which includes a one-time charge of $27.5 million related to the extinguishment <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">of its convertible note on August 19, 2024</a>.
The company sees adjusted EBITDA of approximately $25 million. As of September 30, the company held about $113 million in cash and cash equivalents.
Aspen plans to report third-quarter results <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">on November 7, 2024</a>.
Price Action: ASPN shares are up 13.1% at $25.38 at the last check Wednesday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41360269" target="_blank" rel="noreferrer noopener">Crypto Trader Turns $727 Into $2.44M In 5 Days With Viral AI-Conceived Meme Coin</a></li>
</ul>

Equities

Guidance

Contracts

Small Cap

Movers

Why Aspen Aerogels Shares Are Seeing Blue Skies On Wednesday

WIIM

Aspen Aerogels shares are trading higher after the company announced it won a conditional commitment for a proposed DOE loan worth up to $670.6 million. Also,  the company said it expects its second plant to provide between $1.2 to $1.6 billion in revenue.

U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Wednesday.
Shares of United Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) rose sharply during Tuesday's session following <a href="https://www.benzinga.com/news/earnings/24/10/41345371/united-airlines-q3-earnings-revenue-beat-eps-beat-1-5b-buyback-clear-inflection-point">better-than-expected quarterly earnings.</a>
United Airlines reported third-quarter revenue of $14.843 billion, beating the consensus estimate of $14.783 billion, according to Benzinga Pro. The airline company reported adjusted earnings of $3.33 per share, beating analyst estimates of $3.13 per share.
United Airlines gained 9.3% to $70.04 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Korro Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRRO#NASDAQ">KRRO</a>) gained 80% to $71.72.</li>
<li>Wave Life Sciences Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) jumped 62.5% to $13.91. Wave Life Sciences achieved first-ever therapeutic RNA editing in humans with results from RestorAATion-2 trial of WVE-006 for Alpha-1 Antitrypsin Deficiency.</li>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) gained 21% to $14.20. The DOE approved the company&#8217;s conceptual safety design report for its Aurora fuel fabrication facility. This will advance plans to utilize recovered material for its first commercial powerhouse.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) rose 18.1% to $16.09.</li>
<li>Altus Power, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) gained 18% to $3.5645 after the company announced that a formal review of strategic alternatives has been underway by its Board of Directors. Also, the company reaffirmed its FY24 guidance.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) jumped 15.8% to $71.00.</li>
<li>Lithium Americas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) gained 14.8% to $3.0689 after the company announced it entered into a new investment agreement with General Motors Holdings to establish a joint venture for the purpose of funding, developing, constructing and operating Thacker Pass in Humboldt County, Nevada.</li>
<li>Aspen Aerogels, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NASDAQ">ASPN</a>) surged 14.1% to $25.61. Aspen Aerogells won conditional commitment for proposed DOE loan of up to $670.6 million.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) gained 7.6% to $19.05.</li>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) rose 6.9% to $119.92 after the company reported better-than-expected third-quarter financial results.</li>
<li>U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) gained 5.2% to $49.44 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41329813/jim-cramer-we-need-more-uranium-recommends-this-stock-says-novo-nordisk-doesnt-hold-a-ca">Jim Cramer: &#8216;We Need More Uranium,&#8217; Recommends This Stock; Says Novo Nordisk &#8216;Doesn&#8217;t Hold A Candle&#8217; To Big Pharma Rival</a></li>
</ul>

Intraday Update

Markets

AMPS

KRRO

OKLO

United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday

Proposed loan of up to $670.6 million would fund the remaining CAPEX needed to complete Company's second aerogel plant Interest rate at applicable U.S. Treasury Rate at the time of each cash draw Plant is expected to provide ~$1.2B - $1.6B of incremental&nbsp;PyroThin&#xAE; thermal barrier revenue capacity Project financing structure, with Aspen&nbsp;Aerogels, Inc.'s subsidiary Aspen Georgia, LLC as the borrower
Q3 2024 revenue of $117 million drove $25 million of Adjusted EBITD

Aspen Aerogels Says Second Plant Expected To Provide ~$1.2B-$1.6B In Revenue

Aspen Aerogells Wins Conditional Commitment For Proposed DOE Loan Of Up To $670.6M

Aspen Aerogels's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) short percent of float has risen 8.66% since its last report. The company recently reported that it has 5.99 million shares sold short, which is 10.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Aspen Aerogels Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727790314_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Aspen Aerogels has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Aspen Aerogels's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Aspen Aerogels's peer group average for short interest as a percentage of float is 3.13%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Aspen Aerogels?

Roth MKM analyst Chip Moore reiterates Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Buy and maintains $36 price target.

Roth MKM Reiterates Buy on Aspen Aerogels, Maintains $36 Price Target

TD Cowen analyst Jeffrey Osborne maintains Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Buy and raises the price target from $36 to $41.

TD Cowen Maintains Buy on Aspen Aerogels, Raises Price Target to $41

Excluding New Georgia Facility From Collateral Structure

Aspen Aerogels Secures $125M Term Loan And $100M Revolving Credit Facility With MidCap Financial To Redeem Convertible Note And Support Plant II Financing

As of Aug 19, 2024, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Aspen Aerogels Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>)</h3>
<ul>
<li>On Aug. 7, Aspen Aerogels reported better-than-expected second-quarter revenue results. &#8220;This quarter&#8217;s results demonstrate the significant operating leverage of our business model as we continue to utilize a higher percentage of our current capacity and effectively execute our strategy,&#8221; commented Don Young, Aspen&#8217;s President and CEO. The company's stock gained around 35% over the past five days and has a <a href="https://www.benzinga.com/quote/ASPN">52-week high of $31.74</a>.</li>
<li>RSI Value: 73.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ASPN Price Action: Shares of Aspen Aerogels gained 22.6% to close at $29.92 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Anglogold Ashanti PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>)</h3>
<ul>
<li>On Aug. 6, AngloGold Ashanti reported a year-over-year increase in H1 financial results. &#8220;These results show the hard work that&#8217;s been done to improve the fundamentals of our business, to drive productivity benefits and manage costs to ensure we capture the benefit of stronger gold prices,&#8221; CEO Alberto Calderon said. &#8220;We expect to deliver an even stronger second-half performance.&#8221; The company's stock gained around 12% over the past month and <a href="https://www.benzinga.com/quote/AU">has a 52-week high</a> of $31.65.</li>
<li>RSI Value: 70.53</li>
<li>AU Price Action: Shares of Anglogold Ashanti gained 3.6% to close at $31.47 on Friday.</li>
</ul>
<h3 class="wp-block-heading">United States Antimony Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>)</h3>
<ul>
<li>On Aug. 9, the company said revenues for the first six months of 2024 increased 26%, or $1.169 million, to $5.6 million, compared to the first six months of 2023. The company's stock gained around 71% over the past month and has a <a href="https://www.benzinga.com/quote/UAMY">52-week high</a> of $0.57.</li>
<li>RSI Value: 84.97</li>
<li>UAMY Price Action: Shares of United States Antimony gained 11.6% to close at $0.53 on Friday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40420521/jim-cramer-recommends-buying-clorox-ceo-has-done-remarkable-job">Jim Cramer Recommends Buying Clorox: &#8216;CEO Has Done Remarkable Job&#8217;</a></li>
</ul>

Pre-Market Outlook

UAMY

Top 3 Materials Stocks That May Collapse In Q3

HC Wainwright &amp; Co. analyst Amit Dayal maintains Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Buy and raises the price target from $25 to $30.

HC Wainwright & Co. Maintains Buy on Aspen Aerogels, Raises Price Target to $30

Benchmark analyst Subash Chandra reiterates Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) with a Buy and maintains $14 price target.

Benchmark Reiterates Buy on Aspen Aerogels, Maintains $14 Price Target

Aspen Aerogels shares are trading higher after the company reported better-than-expected Q2 revenue results.

Shares of Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/08/40244718/digital-turbine-q1-results-exceed-estimates-sees-continued-demand-in-h2-fy25">quarterly financial results.</a>
Revenue declined 19% Y/Y to $118.0 million, beating the consensus of $116.03 million. Adjusted EPS stood at 7 cents, surpassing the consensus of 4 cents.
Digital Turbine shares jumped 20.8% to $2.15 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Expion360 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) rose 36.5% to $0.1140 in today's pre-market trading. Expion360 shares dipped 68% on Wednesday after the company priced a $10 million underwritten public offering.</li>
<li>Anew Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WENA#NASDAQ">WENA</a>) gained 25% to $1.360 in pre-market trading. Anew Medical announced the grant and issuance of patent number HK1259628 protecting the development of novel genetic approaches for neurodegenerative diseases to include Alzheimer&#8217;s disease, Parkinson&#8217;s diseases, and amyotrophic lateral sclerosis.</li>
<li>Luxurban Hotels Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) gained 26.3% to $0.12 in pre-market trading after falling 11% on Wednesday.</li>
<li>Coeptis Therapeutics Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) jumped 24.8% to $0.26 in pre-market trading.</li>
<li>Aspen Aerogels Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares gained 21% to $22.38 in pre-market trading after the company reported better-than-expected second-quarter revenue results.</li>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) gained 18% to $93.02 in pre-market trading after the company reported better-than-expected quarterly financial results.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares gained 17.3% to $0.5725 in pre-market trading after surging 39% on Wednesday.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) gained 13.7% to $15.73 in pre-market trading after the company reported better-than-expected third-quarter revenue results..</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares rose 11.4% to $1.56 in pre-market trading after declining 8% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cardlytics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) shares dipped 49.6% to $3.48 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>Outset Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) shares declined 47.1% to $1.80 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY24 revenue guidance.</li>
<li>Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) shares declined 39.8% to $4.85 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Viracta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) declined 38.9% to $0.2744 in pre-market trading.</li>
<li>Greenlane Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares fell 36.1% to $2.59 in pre-market trading after jumping 58% on Wednesday.</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) fell 27.4% to $24.73 pre-market trading after the company reported worse-than-expected second-quarter revenue results. Additionally, the company issued FY24 guidance below estimates.</li>
<li>Know Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNW#NYSE">KNW</a>) fell 21.5% to $0.22 in today's pre-market trading after the company priced its $3.445 million public offering of 13.25m units at $0.26 per unit.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) shares fell 20.7% to $29.89 in pre-market trading after the company reported second-quarter results.</li>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) fell 20.5% to $5.42 in pre-market trading after the company issued FY24 and Q3 guidance below estimates.</li>
<li>Precigen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) shares fell 18.1% to $0.9660 in pre-market trading after the company priced $30 million public offering of 35,294,118 common stock at $0.85/share.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/news/24/08/40218858/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40218858/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

APPS

BMBL

BROS

CDLX

COEP

FLNC

FROG

FSLY

GNLN

LUXH

PGEN

SEZL

STAF

VIRX

WENA

XPON

Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Aspen Aerogels (ASPN) announced that it has commenced an underwritten public offering of 4.25M shares of its common stock. Aspen intends to use the...

Aspen Aerogels announces 4.25M share common stock offering

Goldman Sachs and Morgan Stanley are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for re...

Aspen Aerogels 4.25M share Spot Secondary; price range $19.40-$20.40

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – Flexsteel Industries (FLXS)&n...

Closing Bell Movers: Medpace down 11% after cutting FY24 revenue guide

The deal range was $19.40-$20.40. Goldman Sachs and Morgan Stanley acted as joint book running managers for the offering. Published first on TheFly...

Aspen Aerogels 4.25M share Spot Secondary priced at $20.00

Piper Sandler analyst Alexander Potter lowered the firm's price target on Aspen Aerogels (ASPN) to $33 from $36 and keeps an Overweight rating on t...

Aspen Aerogels price target lowered to $33 from $36 at Piper Sandler

In a report released today, Eric Stine from Craig-Hallum maintained a Buy rating on Aspen Aerogels (ASPN – Research Report). The company's shares c...

Aspen Aerogels (ASPN) Gets a Buy from Craig-Hallum

Unusual total active option classes on open include: Energy Vault Holdings (NRGV), Sangamo (SGMO), Nordstrom (JWN), Philip Morris (PM), Verizon (VZ...

Unusually active option classes on open October 22nd

Benchmark Co. analyst Subash Chandra maintained a Buy rating on Aspen Aerogels (ASPN – Research Report) today and set a price target of $25.00. The...

Benchmark Co. Sticks to Its Buy Rating for Aspen Aerogels (ASPN)

Aspen Aerogels: Interesting Times

RMT: A Micro-Cap Equity Fund For Income Investors, With A Nearly 8% Yield And 12% Discount

BOOM

CAKE

CLBT

CLBTW

CORZ

FLXS

HSTM

IESC

IRTC

MEDP

MLAB

NRGV

SFBS

SGMO

SHLS

TRNS

WASH

ZION

Commodities

Press Releases

Aspen Aerogels Announces Thermal Barrier Award from Valmet Automotive for Electric Porsche 718 Series and Reiterates 2024 Financial Outlook

Aspen Aerogels to Attend 10th Annual ROTH London Conference

Aspen Aerogels, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call

Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference

Aspen Aerogels, Inc. Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aspen Aerogels, Inc. Announces New Appointment to its Board of Directors

Aspen Aerogels, Inc. Announces $125 Million Term Loan and $100 Million Revolving Credit Facility with MidCap Financial, and Full Cash Redemption of Legacy Convertible Note

Comments

Aspen Aerogels

Vendite allo scoperto

Aspen Aerogels (NYSE:ASPN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO